Search
for

    Glossary Liraglutide

    medication mimicking GLP-1 hormone to regulate blood sugar

    Liraglutide is a medication that mimics a hormone called GLP-1 (glucagon-like peptide-1) to help regulate blood sugar levels and appetite. It is commonly used to treat type 2 diabetes under the brand name Victoza and for weight management under the brand name Saxenda.

    Research 10 of 145

    1. Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin European journal of endocrinology · 2013 · 116 citations
    2. A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome Hormones · 2015 · 61 citations
    3. A Disease-Modifying Approach for Advanced Hidradenitis Suppurativa (Regimen with Metformin, Liraglutide, Dapsone, and Finasteride): A Case Report Case Reports in Dermatology · 2017 · 9 citations
    4. Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review 2025 · 1 citations
    5. EFFECTS OF LIRAGLUTIDE ON VISCERAL ADIPOSITY INDEX IN WOMAN OF REPRODUCTIVE AGE WITH PREDIABETES Wiadomości Lekarskie · 2024
    6. Combination of metformin with liraglutide in treating HAIR-AN syndrome in children: A case report and literature review. PubMed · 2023
    7. Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing International Journal of Molecular Sciences · 2022 · 68 citations
    8. GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects Frontiers in Endocrinology · 2021 · 59 citations
    9. Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study Cardiovascular Drugs and Therapy · 2024 · 25 citations
    10. Clinical Effects of Glucagon-Like Peptide-1 Agonist Use for Weight Loss in Women With Polycystic Ovary Syndrome: A Scoping Review Cureus · 2024 · 5 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →